Introduction
Methods
Study population
Echocardiography
Statistical analysis
Results
Baseline variables
Variable | Healthy subset n = 575 | Remaining cohort n = 1275 | p value |
---|---|---|---|
Age (years) | 42 [34, 52] | 58 [49, 65] | < 0.001 |
Female gender, n (%) | 328 (57%) | 631 (49%) | 0.003 |
BSA (m2) | 1.82 [1.70, 1.99] | 1.97 [1.82, 2.13] | < 0.001 |
Weight (kg) | 72 [62, 81] | 86 [74, 98] | < 0.001 |
Height (cm) | 171 [165, 179] | 171 [163, 177] | 0.003 |
BMI (kg/m2) | 24 [22, 26] | 29 [26, 33] | < 0.001 |
Systolic blood pressure (mmHg) | 118 [109, 124] | 132 [121, 144] | < 0.001 |
Diastolic blood pressure (mmHg) | 78 [72, 81] | 83 [78, 90] | < 0.001 |
History of CVD, n (%) | 230 (18%) | ||
Antihypertensive medication, n (%) | 606 (48%) | ||
Diabetes mellitus, n (%) | 171 (13%) | ||
Lipid-lowering drugs, n (%) | 298 (23%) | ||
Total serum cholesterol (mmol/l) | 5.02 [4.42, 5.71] | 5.25 [4.57, 5.92] | < 0.001 |
Total serum triglycerides (mmol/l) | 0.97 [0.73, 1.39] | 1.39 [1.03, 2.02] | < 0.001 |
HDL cholesterol (mmol/l) | 1.51 [1.27, 1.76] | 1.34 [1.10, 1.62] | < 0.001 |
LDL cholesterol (mmol/l) | 2.94 [2.37, 3.58] | 3.05 [2.41, 3.65] | 0.091 |
Age group (n) | < 0.001 | ||
under 40 years | 239 | 160 | |
40–60 years | 283 | 556 | |
over 60 years | 53 | 559 |
Effects of age, gender and measurement method
Variable | Age effect (per 10 years) | Age effect p value | Gender effect (male vs. female) | Gender effect p value |
---|---|---|---|---|
Left ventricular dimensions | ||||
2D method | ||||
LV end-diastolic diameter (mm) | −0.7 [−1.0, − 0.3] | 0.001 | 5.6 [4.3, 7.0] | < 0.001 |
LV end-diastolic diameter, BSA (mm/m2) | −0.4 [− 0.8, − 0.1] | 0.021 | − 1.4 [− 2.5, − 0.4] | 0.007 |
M-mode method | ||||
LV end-diastolic diameter (mm) | 0.5 [− 0.1, 1.2] | 0.113 | 5.4 [4.0, 6.8] | < 0.001 |
LV end-diastolic diameter, BSA (mm/m2) | 0.3 [−0.1, 0.7] | 0.107 | −1.3 [−2.1, − 0.4] | 0.004 |
LV end-systolic diameter (mm) | 0.7 [− 0.2, 1.6] | 0.114 | 4.1 [1.9, 6.2] | < 0.001 |
LV end-systolic diameter, BSA (mm/m2) | 0.4 [−0.1, 0.9] | 0.109 | −0.4 [−1.5, 0.7] | 0.469 |
LV mass and wall thickness | ||||
2D method | ||||
Interventricular septum (mm) | 0.5 [0.1, 0.8] | 0.011 | 1.3 [0.4, 2.3] | 0.004 |
LV Posterior wall (mm) | 0.4 [0.2, 0.6] | < 0.001 | 1.5 [1.0, 2.0] | < 0.001 |
LV mass, BSA (g/m2) | 4.2 [2.1, 6.4] | < 0.001 | 23.5 [18.4, 28.6] | < 0.001 |
M-mode method | ||||
Interventricular septum (mm) | 0.6 [0.3, 0.9] | < 0.001 | 1.7 [0.9, 2.5] | < 0.001 |
LV Posterior wall (mm) | 0.6 [0.4, 0.8] | < 0.001 | 1.6 [1.1, 2.0] | < 0.001 |
LV mass, BSA (g/m2) | 7.1 [3.2, 11.1] | < 0.001 | 22.6 [10.6, 34.5] | < 0.001 |
LV mass, height2.7 (g/m) | 4.2 [2.2, 6.2] | < 0.001 | 4.8 [−0.2, 9.8] | 0.060 |
LV volumes and function | ||||
LV end-diastolic volume (ml) | −6.6 [− 10.0, −3.1] | < 0.001 | 35.4 [25.1, 45.6] | < 0.001 |
LV end-diastolic volume, BSA (ml/m2) | −3.1 [− 6.5, 0.4] | 0.081 | 8.4 [0.9, 16.0] | 0.029 |
LV end-systolic volume (ml) | −3.6 [−5.0, −2.1] | < 0.001 | 23.2 [19.4, 27.0] | < 0.001 |
LV end-systolic volume, BSA (ml/m2) | −2.1 [−3.5, − 0.8] | 0.002 | 6.4 [2.9, 9.9] | < 0.001 |
LV ejection fraction (%) | 1.4 [− 0.1, 2.9] | 0.059 | − 1.6 [−5.7, 2.6] | 0.455 |
Mitral septal s’ (cm/s) | − 0.2 [− 0.4, − 0.1] | 0.001 | −0.1 [− 0.4, 0.3] | 0.658 |
Mitral lateral s’ (cm/s) | − 0.3 [− 0.5, − 0.1] | 0.002 | 0.4 [− 0.1, 0.8] | 0.162 |
Variable | Age effect (per 10 years) | Age effect p value | Gender effect (male vs. female) | Gender effect p value |
---|---|---|---|---|
Left atrium | ||||
LA diameter M-mode (mm) | 0.7 [− 0.2, 1.7] | 0.138 | 4.3 [2.1, 6.6] | < 0.001 |
LA diameter M-mode, BSA (mm/m2) | 1.0 [0.5, 1.4] | < 0.001 | − 1.3 [− 2.2, − 0.3] | 0.009 |
LA vertical diameter (mm) | −0.2 [− 1.4, 1.0] | 0.752 | 4.2 [0.2, 8.2] | 0.042 |
LA horizontal diameter (mm) | 1.1 [−0.0, 2.3] | 0.056 | 1.6 [−1.0, 4.2] | 0.232 |
LA volume (ml) | 1.1 [−2.7, 5.0] | 0.571 | 15.4 [4.0, 26.9] | 0.008 |
LA volume, BSA (ml/m2) | 1.6 [−0.3, 3.5] | 0.097 | 0.2 [−4.8, 5.3] | 0.924 |
Right ventricle | ||||
RV basal diameter (mm) | 0.9 [−0.2, 1.9] | 0.109 | 6.9 [3.7, 10.0] | < 0.001 |
RV basal diameter, BSA (mm/m2) | 0.4 [−0.0, 0.9] | 0.066 | 0.1 [−1.0, 1.2] | 0.839 |
Tricuspid s’ (m/s) | −0.2 [− 0.6, 0.2] | 0.261 | − 0.7 [− 1.6, 0.3] | 0.194 |
TAPSE (mm) | − 0.6 [− 1.5, 0.2] | 0.144 | −0.0 [−2.3, 2.2] | 0.992 |
Right atrium | ||||
RA vertical diameter (mm) | −0.0 [− 0.7, 0.7] | 1.000 | 5.7 [4.1, 7.3] | < 0.001 |
RA horizontal diameter (mm) | −0.5 [−1.4, 0.3] | 0.202 | 6.3 [4.3, 8.3] | < 0.001 |
RA vertical diameter, BSA (mm/m2) | 0.6 [0.1, 1.0] | 0.009 | −1.6 [−2.4, −0.8] | < 0.001 |
RA horizontal diameter, BSA (mm/m2) | 0.1 [−0.4, 0.6] | 0.663 | −0.5 [−1.8, 0.8] | 0.443 |
Aorta | ||||
Aortic root (mm) | 0.8 [−0.1, 1.8] | 0.084 | 5.5 [3.4, 7.7] | < 0.001 |
Aortic root, BSA (mm/m2) | 0.4 [0.0, 0.8] | 0.045 | −0.3 [−1.2, 0.7] | 0.589 |
Estimated cut-off values
Variable | Males | Females | ||||
---|---|---|---|---|---|---|
Abnormal | Moderately abnormal | Severely abnormal | Abnormal | Moderately abnormal | Severely abnormal | |
LV dimensions | ||||||
2D method | ||||||
LV end-diastolic diameter (mm) | > 56 | > 60 | > 63 | > 51 | > 56 | > 58 |
LV end-diastolic diameter, BSA (mm/m2) | > 28 | > 30 | > 31 | > 30 | > 31 | > 32 |
M-mode method | ||||||
LV end-diastolic diameter (mm) | > 60 | > 64 | > 66 | > 55 | > 59 | > 63 |
VLV end-diastolic diameter, BSA (mm/m2) | > 31 | > 32 | > 33 | > 32 | > 33 | > 34 |
LV end-systolic diameter (mm) | > 40 | > 44 | > 49 | > 36 | > 39 | > 41 |
LV end-systolic diameter, BSA (mm/m2) | > 20 | > 21 | > 23 | > 21 | (> 21)a | (> 23)a |
LV mass and wall thickness | ||||||
2D method | ||||||
Interventricular septum (mm) | > 11.5 | > 14.0 | > 15.0 | > 10.3 | > 12.3 | > 13.3 |
Posterior wall (mm) | > 10.7 | > 12.3 | > 13.0 | > 9.3 | > 11.0 | > 11.7 |
LV mass, BSA (g/m2) | > 107 | > 130 | > 138 | > 82 | > 111 | > 128 |
M-mode method | ||||||
Interventricular septum (mm) | > 12.7 | > 14.3 | > 15.0 | > 11.0 | > 12.7 | > 13.7 |
Posterior wall (mm) | > 11.0 | > 13.3 | > 14.0 | > 9.7 | > 11.5 | > 12.3 |
LV mass, BSA (g/m2) | > 122 | > 147 | > 167 | > 104 | > 129 | > 141 |
LV mass, height2.7 (g/m) | > 53 | > 68 | > 76 | > 47 | > 69 | > 76 |
LV volumes and function | ||||||
LV end-diastolic volume (ml) | > 150 | > 181 | > 205 | > 109 | > 136 | > 157 |
LV end-diastolic volume, BSA (ml/m2) | > 73 | > 85 | > 94 | > 63 | > 73 | > 85 |
LV end-systolic volume (ml) | > 69 | > 81 | > 99 | > 44 | > 56 | > 71 |
LV end-systolic volume, BSA (ml/m2) | > 33 | > 39 | > 46 | > 25 | > 30 | > 37 |
LV ejection fraction (%) | < 50 | < 46 | < 42 | < 53 | < 50 | < 47 |
Mitral septal s’ (cm/s) | < 6.0 | < 5.0 | < 4.3 | < 6.0 | < 5.0 | < 4.3 |
Mitral lateral s’ (cm/s) | < 6.3 | < 5.0 | < 4.3 | < 6.0 | < 5.3 | < 5.0 |
Variable | Males | Females | ||||
---|---|---|---|---|---|---|
Abnormal | Moderately abnormal | Severely abnormal | Abnormal | Moderately abnormal | Severely abnormal | |
Left atrium | ||||||
LA diameter M-mode (mm) | > 46 | > 53 | > 56 | > 41 | > 48 | > 51 |
LA diameter M-mode, BSA (mm/m2) | > 23 | > 25 | > 27 | > 24 | > 26 | > 27 |
LA vertical diameter (mm) | > 61 | > 67 | > 71 | > 56 | > 61 | > 63 |
LA horizontal diameter (mm) | > 48 | > 52 | > 54 | > 46 | > 50 | > 54 |
LA volume (ml) | > 86 | > 108 | > 123 | > 70 | > 90 | > 105 |
LA volume, BSA (ml/m2) | > 42 | > 52 | > 59 | > 40 | > 48 | > 53 |
Right ventricle | ||||||
RV basal diameter (mm) | > 46 | > 47 | > 48 | > 39 | > 42 | > 43 |
RV basal diameter, BSA (mm/m2) | > 23 | (> 23)a | (> 24)a | > 23 | (> 24)a | (> 24)a |
Tricuspid s’ (m/s) | < 9.0 | < 8.0 | < 7.0 | < 9.0 | < 8.0 | < 7.7 |
TAPSE (mm) | < 19 | < 17 | < 15 | < 19 | < 18 | < 17 |
Right atrium | ||||||
RA vertical diameter (mm) | > 57 | > 61 | > 65 | > 51 | > 56 | > 58 |
RA horizontal diameter (mm) | > 50 | (> 50)a | (> 53)a | > 42 | > 45 | > 47 |
RA vertical diameter, BSA (mm/m2) | > 28 | > 30 | > 32 | > 30 | > 31 | > 33 |
RA horizontal diameter, BSA (mm/m2) | > 25 | (> 25)a | (> 26)a | > 25 | > 26 | > 27 |
Aorta | ||||||
Aortic root (mm) | > 40 | > 42 | > 43 | > 34 | > 36 | > 37 |
Aortic root, BSA (mm/m2) | > 19 | > 20 | > 21 | > 20 | > 21 | > 22 |